EGFR and non-small cell lung carcinoma: All these researches will be meaningful for guiding the principle of TCM therapies in combination with EGFR-TKIs or avoiding using them together with EGFR-TKIs to delay the resistance to EGFR-TKIs or increase the sensitivity of EGFR-TKIs in EGFR-TKIs-resistant NSCLC models.